North America represents a leading regional market for peptone, backed by sophisticated biomanufacturing infrastructure, high per-capita healthcare spending, and major biotech innovation centers across the US and Canada. Regional growth is bolstered by increasing corporate investments in continuous bioprocessing, rising adoption of single-use bioreactor systems, and collaborative technology...